Mary Evers, DO
Dermatology in Georgetown, TX
About Dr. Mary Evers
Dr. Mary Evers is a physician specializing in dermatology practicing in Georgetown, TX. Treated 1,495 Medicare patients in 2024.
| Specialty | DermatologyOther dermatology doctors in Georgetown |
|---|---|
| Credentials | DO |
| Gender | Female |
| NPI number | 1053533026National Provider Identifier (CMS NPPES), issued May 2007 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Where Dr. Mary Evers practices
- Texas Dermatology Center PLLC 1900 Scenic Dr, Suite 2208, Georgetown, TX 78626 (512) 868-9800 · Directions · group of 110 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Mary Evers' specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Dermatology Primary | TX M6125 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Dr. Mary Evers' Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 5,829 | $6.24 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,563 | $87.11 |
| Destruction of precancer skin growth, 1 growth | 1,233 | $45.45 |
| Biopsy of related skin growth, first growth | 896 | $85.49 |
| Destruction of precancer skin growth, 15 or more growths | 763 | $159 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 739 | $122.25 |
| Destruction of skin growth, 1-14 growths | 520 | $105.79 |
| Biopsy of related skin growth, each additional growth | 257 | $47.59 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Mary Evers' Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Mary Evers (2025)
$145.36 in 6 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 6 | $145.36 |
Paying companies: Genzyme Corporation ($63.96), NOVARTIS PHARMACEUTICALS CORPORATION ($31.72), Biofrontera Inc. ($20.12), UCB, Inc. ($14.87), Journey Medical Corporation ($14.69).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Mary Evers
What kind of clinician is Dr. Mary Evers?
Dr. Mary Evers is listed as a physician specializing in dermatology.
Where does Dr. Mary Evers practice?
Texas Dermatology Center PLLC at 1900 Scenic Dr, Suite 2208, Georgetown, TX 78626.
What is the office phone number for Dr. Mary Evers?
The listed office number is (512) 868-9800. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Mary Evers?
The National Provider Identifier is 1053533026.
Does Dr. Mary Evers accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2019-07-23 |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.